GO
Loading...

Stop Trading!: Vytorin Panic = Buy


Just because the FDA is issuing an ‘early communication’ on Merck and Schering-Plough’scholesterol drug Vytorin doesn’t mean it will get pulled, Cramer said on Friday’s Stop Trading! segment. He said that shares of both companies are being sold off in a case of panic and “classic headline overreaction.”

Cramer insisted that he would buy both Merck and Schering . Even if Vytorin ends up being a lost cause, which he doesn’t think it will, it’s not the only important drug in the pipeline for either Big Pharma behemoth.

On Thursday’s government stimulus plan that increases the mortgage cap on Fannie Mae and Freddie Mac , Cramer lamented that government-backed lenders are still “not invest-able.” As long as Fannie and Freddie continue to be “overwhelmed,” Cramer said, they are liable to make mistakes. He said that the stimulus plan could help Thornburg Mortgage and Toll Brothers .


Jim's charitable trust owns Schering-Plough.

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
FNMA
---
FMCC
---
MRK
---
TOL
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.